It’s a quite week for IPOs this week.
Passage BIO, the preclinical biotech developing gene therapies for rare CNS disorders, will go public this week.
Shares are likely to be priced on Thursday, February 27, 2020.
If you want access to this IPO, please be sure to join the IPO Wait List by download the app for iOS or Android.
Enjoy the week!
Have a great day,
p.s. Here’s a the Passage Bio Prospectus if you’re interested.